期刊文献+

遗传性甲状腺髓样癌的诊断及外科处理 被引量:2

下载PDF
导出
摘要 甲状腺髓样癌(Illedullary thyroid carcinOma.MTC)来源于甲状腺滤泡旁细胞.约占甲状腺恶性肿瘤的4%.其中25%~30%属遗传性。遗传性MTC(HMTC)分为多发内分泌肿瘤2A型(MEN.2A1、多发内分泌肿瘤2B型(MEN一2B)和家族性甲状腺髓样癌(FMTCl3种类型。MTC是MEN一2的主要病变.也是最早出现的病变.是MEN一2病人的主要死因。
出处 《外科理论与实践》 2013年第6期586-589,共4页 Journal of Surgery Concepts & Practice
  • 相关文献

参考文献3

二级参考文献44

  • 1李树玲.我国甲状腺癌外科现状与展望[J].临床外科杂志,2006,14(3):129-130. 被引量:46
  • 2李小英.多发性内分泌腺瘤病[J].中国实用内科杂志:临床前沿版,2006,26(11):1763-1766. 被引量:26
  • 3Frates MC, Benson CB, Charhoneaff JW, et M. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement [J]. Radiology, 2005,237 (3):794-800.
  • 4Haymarl MR, Repplingcr DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage [J]. J Clin Endocrinol Metab ,2008,93(3): 809-814.
  • 5Layfield LJ, Cibas ES, Gharib H, et al. Thyroid aspiration cytology: current status [J]. CA Cancer J Clin ,2009,59(2):99-110.
  • 6Machens A, Dralle H. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside[J]. Mol Cell Endoerinol,2006, 247 ( 1-2 ): 34-40.
  • 7Costante G, Meringolo D, Durante C, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules [J]. J Clin Endocrinol Metab,2007,92 (2): 450-455.
  • 8Herbert Chen, Rebecca S, Sue O' Dorisio SM, et al. The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer[J]. Pancreas,2010,39(6): 775-783.
  • 9Barber J, Campion L, Kraeber-Bodere F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma [J].J Clin Endocrinol Metab, 2005,90( 11 ): 6077-6084.
  • 10Roman S, Mehta P,Sosa JA. Medullary thyroid cancer: early detection and novel treatments [J ]. Curr Opin Oncol, 2009,21 (1) : 5-10.

共引文献48

同被引文献31

  • 1Wartofsky L. Increasing world incidence of thyroid cancer: incre- ased detection or higher radiation exposure ? [J]. Hormones (Athens), 2010, 9(2): 103-108.
  • 2Kazaure HS, Roman SA, Sosa JA. Medullary thyroid microcar- cinoma: a population-level analysis of 310 patients [ J ]. Cancer, 2012, 118(3): 620-627.
  • 3Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary thyroid cancer [J]. Oncologist, 2008, 13(5): 539-547.
  • 4Schulten H J, AI-Maghrabi J, A1-Ghamdi K, et al. Mutational screening ofRET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNBI in medullary thyroid carcinoma [J]. Anticancer Res, 2011, 31(12): 4179-4183.
  • 5de Groot JW, Links TP, Plukker JT, et al. RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors[J]. Endocr Rev, 2006, 27(5): 535-560.
  • 6Elisei R, Cosci B, Romei C, et al. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study [J]. J Clin Endocrinol Metab, 2008, 93(3): 682-687.
  • 7Segouffin-Cariou C, Billaud M. Transforming ability of MEN2A- RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway [J]. J Biol Chem, 2000, 275(5): 3568-3576.
  • 8Sherman SI. Advances in chemotherapy of differentiated epithe- lial and medullary thyroid cancers [J]. J Clin Endocrinol Metab, 2009, 94(5): 1493-1499.
  • 9Guleng B, Tateishi K, Ohta M, et al. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor- independent manner [J]. Cancer Res, 2005, 65(13): 5864- 5871.
  • 10Gild ML, Bullock M, Robinson BG, et aL Multikinase inhibi- tors: a new option for the treatment of thyroid cancer ~ J ]. Nat Rev Endocrinol, 2011, 7(10): 617-624.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部